Ferucarbotran-Enhanced Magnetic Resonance Imaging Versus Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Preoperative Detection of Hepatocellular Carcinoma: Initial Experiencele
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Ji Young | - |
dc.contributor.author | Kim, Seong Hyun | - |
dc.contributor.author | Jeon, Yong Hwan | - |
dc.contributor.author | Lee, Jongmee | - |
dc.contributor.author | Kim, Min Ju | - |
dc.contributor.author | Choi, Dongil | - |
dc.contributor.author | Lee, Won Jae | - |
dc.date.accessioned | 2021-09-08T06:09:27Z | - |
dc.date.available | 2021-09-08T06:09:27Z | - |
dc.date.created | 2021-06-11 | - |
dc.date.issued | 2010-01 | - |
dc.identifier.issn | 0363-8715 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/117276 | - |
dc.description.abstract | We compared the diagnostic performance of ferucarbotran-enhanced magnetic resonance imaging (MRI) with that of gadoxetic acid-enhanced MRI for the preoperative detection of hepatocellular carcinoma (HCC) of 27 consecutive patients (male-female, 21:6; 33-7.6 years) with 38 surgically proven HCCs (mean diameter, 2.8 cm; range, 0.8-10.2 cm) on a 3.0-T unit. Three observers independently reviewed each MR image in a random order on a tumor-by-tumor basis. The diagnostic accuracy of these techniques for the detection of HCC, sensitivity, positive and negative predictive values was evaluated. For each observer, the values of the area under the receiver operating characteristic curve (Az) were 1.000, 1.000, and 0.974 for ferucarbotran-enhanced MRI and 1.000, 0.987, and 1.000 for gadoxetic acid-enhanced MRI, and the differences were not statistically significant between 2 techniques for each observer (P > 0.05). For each observer, sensitivities were 100%, 100%, and 92.1% for ferucarbotran-enhanced MRI and 100%, 94.7%, and 100% for gadoxetic acid-enhanced MRI with no statistical significance (P > 0.005). The differences of the positive and negative predictive values of 2 techniques for each observer were not statistically significant (P > 0.05). Ferucarbotran-enhanced MRI and gadoxetic acid-enhanced MRI show a similar diagnostic performance for the preoperative detection of HCCs. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.subject | FOCAL LIVER-LESIONS | - |
dc.subject | GD-EOB-DTPA | - |
dc.subject | MR CONTRAST AGENT | - |
dc.subject | CLINICAL-EVALUATION | - |
dc.subject | CIRRHOTIC LIVER | - |
dc.subject | HEPATIC-LESIONS | - |
dc.subject | GADOLINIUM | - |
dc.subject | CT | - |
dc.subject | SENSITIVITY | - |
dc.subject | NODULES | - |
dc.title | Ferucarbotran-Enhanced Magnetic Resonance Imaging Versus Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Preoperative Detection of Hepatocellular Carcinoma: Initial Experiencele | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Jongmee | - |
dc.contributor.affiliatedAuthor | Kim, Min Ju | - |
dc.identifier.doi | 10.1097/RCT.0b013e3181b1587a | - |
dc.identifier.scopusid | 2-s2.0-76449088581 | - |
dc.identifier.wosid | 000274272300023 | - |
dc.identifier.bibliographicCitation | JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, v.34, no.1, pp.127 - 134 | - |
dc.relation.isPartOf | JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY | - |
dc.citation.title | JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY | - |
dc.citation.volume | 34 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 127 | - |
dc.citation.endPage | 134 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | FOCAL LIVER-LESIONS | - |
dc.subject.keywordPlus | GD-EOB-DTPA | - |
dc.subject.keywordPlus | MR CONTRAST AGENT | - |
dc.subject.keywordPlus | CLINICAL-EVALUATION | - |
dc.subject.keywordPlus | CIRRHOTIC LIVER | - |
dc.subject.keywordPlus | HEPATIC-LESIONS | - |
dc.subject.keywordPlus | GADOLINIUM | - |
dc.subject.keywordPlus | CT | - |
dc.subject.keywordPlus | SENSITIVITY | - |
dc.subject.keywordPlus | NODULES | - |
dc.subject.keywordAuthor | ferucarbotran | - |
dc.subject.keywordAuthor | gadoxetic acid | - |
dc.subject.keywordAuthor | MRI | - |
dc.subject.keywordAuthor | hepatocellular carcinoma | - |
dc.subject.keywordAuthor | diagnosis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.